Geneva Capital Management’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$82.6M Sell
1,405,173
-390,334
-22% -$24M 1.89% 16
2026
Q1
$117M Buy
1,795,507
+68,106
+4% +$4.84M 2.49% 10
2025
Q4
$120M Sell
1,727,401
-131,284
-7% -$9.22M 2.25% 13
2025
Q3
$129M Sell
1,858,685
-19,080
-1% -$1.36M 2.21% 12
2025
Q2
$140M Buy
1,877,765
+131,937
+8% +$10.2M 2.35% 12
2025
Q1
$142M Buy
1,745,828
+176,152
+11% +$15.3M 2.64% 8
2024
Q4
$140M Sell
1,569,676
-21,128
-1% -$2.13M 2.43% 10
2024
Q3
$183M Buy
1,590,804
+27,339
+2% +$2.86M 3.06% 4
2024
Q2
$149M Buy
1,563,465
+35,209
+2% +$3.17M 2.71% 6
2024
Q1
$126M Sell
1,528,256
-29,933
-2% -$2.48M 2.22% 11
2023
Q4
$137M Buy
1,558,189
+146,778
+10% +$12M 2.59% 4
2023
Q3
$121M Buy
1,411,411
+737
+0.1% +$66.7K 2.55% 5
2023
Q2
$132M Sell
1,410,674
-714
-0.1% -$67.2K 2.6% 4
2023
Q1
$141M Buy
1,411,388
+18,870
+1% +$1.92M 2.87% 3
2022
Q4
$138M Sell
1,392,518
-1,921
-0.1% -$187K 3.1% 4
2022
Q3
$122M Buy
1,394,439
+53,718
+4% +$5.09M 2.82% 3
2022
Q2
$123M Buy
1,340,721
+98,906
+8% +$9.32M 2.82% 2
2022
Q1
$134M Sell
1,241,815
-2,584
-0.2% -$249K 2.59% 2
2021
Q4
$145M Sell
1,244,399
-27,631
-2% -$3.25M 2.34% 5
2021
Q3
$144M Sell
1,272,030
-7,269
-0.6% -$784K 2.44% 2
2021
Q2
$114M Sell
1,279,299
-19,264
-1% -$1.8M 1.86% 8
2021
Q1
$127M Sell
1,298,563
-28,374
-2% -$2.66M 2.16% 5
2020
Q4
$119M Buy
1,326,937
+37,007
+3% +$2.95M 2.02% 8
2020
Q3
$92.9M Buy
1,289,930
+30,428
+2% +$2.42M 1.92% 10
2020
Q2
$102M Buy
1,259,502
+37,664
+3% +$2.71M 2.21% 5
2020
Q1
$87.9M Buy
+1,221,838
New +$88.7M 2.5% 3

Other funds holding EXPO

Geneva Capital Management's EXPO Position: Q2 2026 in Review

Geneva Capital Management reduced its Exponent (EXPO) stake by 22% in Q2 2026, selling an estimated $24M and leaving 1,405,173 shares worth $82.6M. The position accounts for 1.89% of the portfolio, ranked #16.

Geneva Capital Management first reported a position in EXPO in Q1 2020 and has held it in 26 quarters since. The position peaked at $183M in Q3 2024. 340 funds tracked by Wall St. Rank hold EXPO as of Q2 2026.

  • Geneva Capital Management held 1,405,173 shares of Exponent worth $82.6M as of Q2 2026.
  • Geneva Capital Management sold 390,334 Exponent shares in Q2 2026, an estimated $24M.
  • Exponent made up 1.89% of Geneva Capital Management's portfolio in Q2 2026, its #16 holding.
  • Geneva Capital Management first reported a position in Exponent in Q1 2020 and has held it in 26 quarters since.
  • Geneva Capital Management's Exponent position peaked at $183M in Q3 2024.
  • 340 funds tracked by Wall St. Rank held Exponent as of Q2 2026.

Based on Geneva Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.